Skip to main content
OpenTrials

Clinical trial condition

Pseudomonas Infections

Explore clinical trials studying Pseudomonas Infections. Study availability and eligibility vary by location and protocol.

96 public trials 13 recruiting studies
Refine in advanced search Browse all conditions

Pseudomonas Infections trial results

Completed

Aztreonam for Inhalation Solution vs Tobramycin Inhalation Solution in Patients With Cystic Fibrosis & Pseudomonas Aeruginosa

NCT00757237

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • Anchorage, Alaska, United States
  • Phoenix, Arizona, United States
  • Tuscon, Arizona, United States
  • Orange, California, United States
View all 92 locations
View Trial Details
Completed

Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis (CF) Patients With Pseudomonas Aeruginosa (PA)

NCT00128492

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • Birmingham, Alabama, United States
  • Anchorage, Alaska, United States
  • Phoenix, Arizona, United States
  • Little Rock, Arkansas, United States
View all 65 locations
View Trial Details
Completed

International Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa

NCT00112359

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Pediatric Breathing Disorders Clinic Anchorage, Alaska, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
View all 53 locations
View Trial Details
Completed

Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa

NCT00104520

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • University of California, San Diego La Jolla, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
View all 56 locations
View Trial Details
Completed

Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Patients With Cystic Fibrosis, Mild Lung Disease, and P. Aeruginosa

NCT00712166

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +12 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • University Medical Center Tucson, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • University of Arkansas for Medical Sciences, Division of Pulmonary and Critical Care Medicine Little Rock, Arkansas, United States
View all 40 locations
View Trial Details
Completed

Study To Evaluate The Efficacy And Safety Of Ciprofloxacin Extended-Release (Cipro® XR) 1000 mg Tablets Given Once Daily For 7 To 14 Days In The Treatment Of Patients 18 Years Or Older With Complicated Urinary Tract Infections Caused By Pseudomonas Aeruginosa And Other Common Uropathogens

NCT00481689

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Female Urogenital Diseases, +8 more
Locations
  • Birmingham, Alabama, United States
  • Birmingham, Alabama, United States
  • Huntsville, Alabama, United States
  • Scottsdale, Arizona, United States
View all 35 locations
View Trial Details

Related conditions